W e’re almost at the point where AI can no longer be simply defined as an emerging technology. It’s here, and it’s booming. According to McKinsey, more than 70% of companies ...
BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...